The biotech venture capital crunch
Вставка
- Опубліковано 10 кві 2023
- Biotech venture capital investment is slowing down, and startups may have a hard time raising. We explain the money behind why venture investors are changing how they invest, and what it means for founders.
This video is sponsored by Sage Intacct. Learn more here: sageintacct.com/biotech - Наука та технологія
Another great video! Thank you! Your channel is in very underrepresented niche and such educational content is difficult to find, especially on how to conduct research before investing. I hope continuing with the channel is worth your time. There is a lot of us grateful on the other side.
Always great info from Bay Bridge Bio. Thanks Richard!
What a great high quality video. Not clue why it was recommended to me but I'm really glad it was! Hope you get the views you deserve!
Great content, thank you Richard!
Great video! Thanks!
Awesome content Richard! Keep the analysis videos coming :-)
Legend. Best channel.
look for INVITAE ❤❤❤❤❤❤❤its my absolute favourite healthcare company
Cereno Scientific NeXT ❤
I think you should make a video about the biotech sector with its current situation in the disinflation environment (CPI going down) with interest rates peaking with a possible rate pause. Also, the recent banking crisis having a negative impact on biotech. XBI was in an uptrend from the start of 2023 but the recent banking crisis made it come down again.
Do you have any thoughts about Takeda's Qdenga vaccine?
in hindsight the downturn was caused by a lot of small early clinical to preclinical start up going public, receiving mountains of cash from braindead investors then those investors crying after not following the golden rule of biotech/pharma "90% of drugs fail to get through the clinic"
So it doesn't seem like to me biotech had the problem , the problem are venture capital bros who don't understand what they are investing in because they played they were lucky on the stock market or born into money, or they went to an ivy league school and people gave them money under assumption they were intelligent.
The problem was too many stupid people had too much money, and we will see the same exact behavior with AI start ups and it will be even more volatile because they don't have to go through anything like the FDA to get to market.
part of our problem is a problem of culture and assuming a lot of money means a person is intelligent or we will keep repeating the same mistakes with every tech sector until we get some better investors, because most won't say it , but most of them want to be the next Martin Shkreli minus the prison.